US2016319334A1PendingUtilityA1

Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays

Assignee: CORNELL RES FOUNDATION INCPriority: Feb 9, 1996Filed: Dec 8, 2015Published: Nov 3, 2016
Est. expiryFeb 9, 2016(expired)· nominal 20-yr term from priority
B01J 2219/00626B01J 2219/00596B01J 2219/00432C12Q 1/6876B01J 2219/00729B01J 2219/00608B01J 2219/0059B01J 2219/00621B01J 2219/00659C40B 60/14B01J 2219/00529B01J 2219/00637B01J 2219/00711B01J 2219/00605B01J 2219/00527C40B 40/06C12Q 1/6827C12Q 1/6837C12Q 2600/156B82Y 30/00B01J 19/0046B01J 2219/00536B01J 2219/00612B01J 2219/00585C12Q 1/6816B01J 2219/0061B01J 2219/00722
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention describes a method for identifying one or more of a plurality of sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences. The method includes a ligation phase, a capture phase, and a detection phase. The ligation phase utilizes a ligation detection reaction between one oligonucleotide probe, which has a target sequence-specific portion and an addressable array-specific portion, and a second oligonucleotide probe, having a target sequence-specific portion and a detectable label. After the ligation phase, the capture phase is carried out by hybridizing the ligated oligonucleotide probes to a solid support with an array of immobilized capture oligonucleotides at least some of which are complementary to the addressable array-specific portion. Following completion of the capture phase, a detection phase is carried out to detect the labels of ligated oligonucleotide probes hybridized to the solid support.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A method for identifying one or more of a plurality of sequences differing by one or more single-base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences comprising:
 providing a sample potentially containing one or more target nucleotide sequences with a plurality of sequence differences;   providing a plurality of oligonucleotide probe sets, each set characterized by (a) a first oligonucleoti de probe, having an oligonucleotide target-specific portion and an oligonucleotide addressable array-specific portion, wherein the oligonucleotide addressable array-specific portion is separate and distinct from the oligonucleotide target-specific portion, and (b) a second oligonucleotide probe, having a target-specific portion and a detectable reporter label, wherein the oligonucleotide probes in a particular set are suitable for ligation together when hybridized adjacent to one another on a corresponding target nucleotide sequence, but have a mismatch which interferes with such ligation when hybridized to any other nucleotide sequence present in the sample;   providing a ligase,   blending the sample, the plurality of oligonucleotide probe sets, and the ligase to form a mixture;   subjecting the mixture to one or more ligase detection reaction cycles comprising a denaturation treatment, wherein any hybridized oligonucleotides are separated from the target nucleotide sequences, and a hybridization treatment, wherein the oligonucleotide probe sets hybridize at adjacent positions in a base-specific manner to their respective target nucleotide sequences, if present in the sample, and ligate to one another to form a ligated product sequence containing (a) the addressable array-specific portion, (b) the target-specific portions connected together, and (c) the detectable reporter label, and, wherein the oligonucleotide probe sets may hybridize to nucleotide sequences in the sample other than their respective target nucleotide sequences but do not ligate together due to a presence of one or more mismatches and individually separate during the denaturation treatment;   providing a solid support with different capture oligonucleotides immobilized at particular sites, wherein the capture oligonucleotides have nucleotide sequences complementary to the addressable array-specific portions;   contacting the mixture, after said subjecting, with the solid support under conditions effective to hybridize the addressable array-specific portions to the capture oligonucleotides in a base-specific manner, thereby capturing the addressable array-specific portions on the solid support at the site with the complementary capture oligonucleotide; and   detecting the reporter labels of ligated product sequences captured to the solid support at particular sites, thereby indicating the presence of one or more target nucleotide sequences in the sample.   
     
     
         2 . An array of oligonucleotides on a solid support comprising:
 a solid support having an array of positions each suitable for attachment of an oligonucleotide;   a linker or support suitable for coupling an oligonucleotide to the solid support attached to the solid support at each of the array positions; and   an array of oligonucleotides on the solid support with at least some of the array positions being occupied by oligonucleotides having greater than sixteen nucleotides.   
     
     
         3 . A kit for identifying one or more of a plurality of sequences differing by single-base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences comprising:
 a ligase;   a plurality oligonucleotide probe sets, each characterized by (a) a first oligonucleotide probe, having a target sequence-specific portion and an addressable array-specific portion, and (b) a second oligonucleotide probe, having a target sequence-specific portion and detectable reporter label, wherein the oligonucleotide probes in a particular set are suitable for ligation together when hybridized adjacent to one another on a respective target nucleotide sequence, but have a mismatch which interferes with such ligation when hybridized to any other nucleotide sequence, present in the sample; and   a solid support with capture oligonucleotides immobilized at particular sites, wherein the capture oligonucleotides have nucleotide sequences complementary to the addressable array-specific portions.

Join the waitlist — get patent alerts

Track US2016319334A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.